Clinical characteristics and treatment efficacy in patients with primary severe IGF-1 deficiency treated with recombinant IGF-1

• Autori principali: Dovile Denaite (Autore), Ruta Navardauskaite (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Aim of the studyTo evaluate the clinical characteristics and treatment efficacy of patients with severe primary IGF-1 deficiency (PSIGFD) using a recombinant IGF-1 (rhIGF-1).Objectives of the studyTo examine the clinical characteristics of patients with PSIGFD before starting treatment with a rIGF-1...